S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
SWOG Cancer Research Network
International University of Health and Welfare
Marmara University
University of Iowa
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shengjing Hospital
Chang Gung Memorial Hospital
University of Aarhus
University of California, San Diego
British Columbia Cancer Agency
Hospice of Henderson County, Inc.
National Cancer Institute (NCI)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Mundipharma Research GmbH & Co KG
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Sheffield Children's NHS Foundation Trust
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Illinois College of Medicine at Peoria
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
University of Vermont
Mayo Clinic
Mundipharma SAS
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University Hospitals Cleveland Medical Center
S.L.A. Pharma AG
Northwestern University
Northwestern University
Northwestern University
Novartis
Novartis
Novartis
Rigshospitalet, Denmark